C.Q. Pharmaceutical Holding Co Ltd (SHE:000950) — Market Cap & Net Worth
Market Cap & Net Worth: C.Q. Pharmaceutical Holding Co Ltd (000950)
C.Q. Pharmaceutical Holding Co Ltd (SHE:000950) has a market capitalization of $1.54 Billion (CN¥10.52 Billion) as of April 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #7496 globally and #1697 in its home market, demonstrating a -1.77% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying C.Q. Pharmaceutical Holding Co Ltd's stock price CN¥6.09 by its total outstanding shares 1728184696 (1.73 Billion).
C.Q. Pharmaceutical Holding Co Ltd Market Cap History: 2015 to 2026
C.Q. Pharmaceutical Holding Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.29 Billion to $1.54 Billion (-0.01% CAGR).
C.Q. Pharmaceutical Holding Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how C.Q. Pharmaceutical Holding Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
C.Q. Pharmaceutical Holding Co Ltd's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.81x
C.Q. Pharmaceutical Holding Co Ltd's market cap is 4.81 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.29 Billion | $19.42 Billion | $393.81 Million | 0.12x | 5.80x |
| 2016 | $2.24 Billion | $20.49 Billion | $264.42 Million | 0.11x | 8.48x |
| 2017 | $2.57 Billion | $21.19 Billion | $1.11 Billion | 0.12x | 2.32x |
| 2018 | $1.20 Billion | $25.80 Billion | $690.67 Million | 0.05x | 1.74x |
| 2019 | $1.38 Billion | $33.84 Billion | $788.02 Million | 0.04x | 1.75x |
| 2020 | $1.26 Billion | $45.22 Billion | $884.34 Million | 0.03x | 1.42x |
| 2021 | $1.24 Billion | $62.52 Billion | $1.01 Billion | 0.02x | 1.24x |
| 2022 | $1.25 Billion | $67.83 Billion | $952.28 Million | 0.02x | 1.32x |
| 2023 | $1.24 Billion | $78.40 Billion | $624.63 Million | 0.02x | 1.98x |
| 2024 | $1.36 Billion | $80.56 Billion | $282.99 Million | 0.02x | 4.81x |
Competitor Companies of 000950 by Market Capitalization
Companies near C.Q. Pharmaceutical Holding Co Ltd in the global market cap rankings as of April 18, 2026.
Key companies related to C.Q. Pharmaceutical Holding Co Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #204 globally with a market cap of $106.12 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #366 globally with a market cap of $63.72 Billion USD.
- AmerisourceBergen Corporation (STU:ABG): Ranked #395 globally with a market cap of $59.07 Billion USD ( €50.53 Billion EUR).
- Cardinal Health Inc (NYSE:CAH): Ranked #474 globally with a market cap of $50.36 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #204 | McKesson Corporation | NYSE:MCK | $106.12 Billion | $866.38 |
| #366 | Cencora Inc. | NYSE:COR | $63.72 Billion | $327.56 |
| #395 | AmerisourceBergen Corporation | STU:ABG | $59.07 Billion | €275.90 |
| #474 | Cardinal Health Inc | NYSE:CAH | $50.36 Billion | $213.99 |
C.Q. Pharmaceutical Holding Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, C.Q. Pharmaceutical Holding Co Ltd's market cap moved from $2.29 Billion to $ 1.54 Billion, with a yearly change of -0.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.54 Billion | +4.64% |
| 2025 | CN¥1.47 Billion | +8.18% |
| 2024 | CN¥1.36 Billion | +9.83% |
| 2023 | CN¥1.24 Billion | -1.22% |
| 2022 | CN¥1.25 Billion | +0.91% |
| 2021 | CN¥1.24 Billion | -1.12% |
| 2020 | CN¥1.26 Billion | -8.82% |
| 2019 | CN¥1.38 Billion | +14.74% |
| 2018 | CN¥1.20 Billion | -53.17% |
| 2017 | CN¥2.57 Billion | +14.41% |
| 2016 | CN¥2.24 Billion | -1.88% |
| 2015 | CN¥2.29 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 18th, 2026 the market cap of C.Q. Pharmaceutical Holding Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.54 Billion USD |
| MoneyControl | $1.54 Billion USD |
| MarketWatch | $1.54 Billion USD |
| marketcap.company | $1.54 Billion USD |
| Reuters | $1.54 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About C.Q. Pharmaceutical Holding Co Ltd
C.Q. Pharmaceutical Holding Co., Ltd. engages in the wholesale and retail of medicines and medical devices. The company is involved in the pharmaceutical commerce, warehousing logistics, pharmaceutical industry, and research and development businesses. It also engages in the hospital pure sales, commercial wholesale, retail chain, warehousing logistics, and supply chain value-added services for d… Read more